European Archives - Page 609 of 1059 - European Medical Journal

New Guidelines for Stroke Care During the COVID-19 Pandemic

New Guidelines for Stroke Care During the COVID-19 Pandemic

BLOOD clotting increases have been observed in patients with COVID-19, which raises their risk of conditions such as stroke…

Early Alzheimer’s Disease Visualised with New Imaging Tool

Early Alzheimer’s Disease Visualised with New Imaging Tool

Alzheimer’s disease (AD) is rarely diagnosed before symptom onset, and accurate biomarkers of disease progression are limited…

The COVID-19 Conundrum and Cancer – Making Perfect Sense of Imperfect Data

March 11th 2020 marked the day that the World Health Organization (WHO) escalated the coronavirus SARS-CoV-2 (COVID-19) outbreak from a public health…

AbbVie Symposium at ECCO 2020: The Illusion of Remission

AbbVie Symposium at ECCO 2020: The Illusion of Remission

“The Illusion of Remission,” presented at the 15th congress of the European Crohn’s and Colitis Organisation (ECCO) in Vienna, Austria, included…

Doctor Scott Lilly

Chair of the Early Career Professional Council at the American College of Cardiology Interventional Cardiologist, Ross Heart Hospital…

Professor David E. Lanfear

Section Head, Advanced Heart Failure and Transplant Cardiology; Co-Director, Center for Individualized and Genomic Medicine Research, Henry Ford Hospital…

Highlights of the European Organisation for Research and Treatment of Cancer-Cutaneous Lymphoma Task Force (EORTC-CLTF) Annual Congress 2019 (Athens, Sept 26-28): Experiences with Chlormethine Gel in Mycosis Fungoides Cutaneous T-Cell Lymphoma (MF-CTCL)

MF-CTCL is a rare type of cutaneous non-Hodgkin’s lymphoma where uncontrolled growth of the pathological skin-homing T-lymphocytes results first in skin…

EMJ Dermatology 8 [Suppl 3] 2020

The European Organisation for Research and Treatment of Cancer-Cutaneous Lymphoma Task Force (EORTC-CLTF) Annual Meeting hosted in the Greek…

EMJ Hematology 8 [Suppl 3] 2020

EMJ are proud to present the latest highlights from two symposia. The first, entitled “Beyond Clinical Trials in B-Cell Malignancies…

Beyond Clinical Trials in B-Cell Malignancies: What Real-World Experience Tells Us

The Kite, a Gilead company, symposium “Beyond Clinical Trials in B-Cell Malignancies: What Real-World Experience Tells Us” took place as part of the 24th…